Niu X H
Department of Orthopedic Oncology Surgery, Beijing Jishuitan Hospital, Beijing 100035, China.
Zhonghua Wai Ke Za Zhi. 2020 Jun 1;58(6):430-434. doi: 10.3760/cma.j.cn112139-20200204-00061.
The specialty of bone cancer has developed rapidly in China in recent years, but because of the low incidence of these diseases and the unbalanced development of different regions, the malpractice problem of diagnosis and treatment is still outstanding.The NCCN clinical practice guide for bone cancer in the United States has been updated for several years and is now more mature and has been recognized worldwide.It can provide reference for medical professionals in related fields in China, it covers the most common bone tumors such as osteosarcoma, Ewing's sarcoma, chondrosarcoma, giant cell tumor of bone and chordoma.This article describes and interprets the core diagnostic and therapeutic contents of NCCN clinical practice guide for bone cancers.
近年来，骨癌专业在中国发展迅速，但由于这些疾病发病率低且不同地区发展不平衡，诊疗中的不当问题仍然突出。美国国立综合癌症网络（NCCN）骨癌临床实践指南已更新多年，目前更加成熟并已得到全球认可。它可为中国相关领域的医学专业人员提供参考，涵盖骨肉瘤、尤因肉瘤、软骨肉瘤、骨巨细胞瘤和脊索瘤等最常见的骨肿瘤。本文描述并解读了NCCN骨癌临床实践指南的核心诊断和治疗内容。
